316 articles in this topic
Study identifies blood markers that distinguish long-term survivors from short-term survivors in brain cancer treatment.
Ezabenlimab combined with chemotherapy and radiation therapy offers new treatment approach for stage 3 anal cancer patients.
Researchers report on ezabenlimab treatment combined with chemotherapy and radiation for stage 3 anal cancer patients.
Scientists discover how to reprogram cancer cells into harmless, non-dividing cells by targeting a nuclear enzyme pathway.
Comprehensive review reveals how rapid diagnostic devices could revolutionize neuroblastoma detection in children.
Comprehensive review reveals how mitochondrial dysfunction fuels cancer progression and identifies promising therapeutic opportunities.
Redirecting glucose metabolism during T cell expansion dramatically improves cancer immunotherapy effectiveness.
Widely-used anesthetic triggers immune system to attack tumors and enhances checkpoint inhibitor therapy effectiveness.
Study reveals how common cancer drugs trigger dormant tumor cells to reactivate and spread, offering new prevention strategies.
Major trial finds radiofrequency ablation as effective as surgery for small hepatocellular carcinoma, with fewer complications.
Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.
Engineered immune cells target liver cancer protein in phase I safety study, though trial ended early with 10 patients.
